The vast majority of Medicare Part D beneficiaries still don't choose the cheapest plans that meet their medication needs
- PMID: 23048107
- PMCID: PMC3470484
- DOI: 10.1377/hlthaff.2012.0087
The vast majority of Medicare Part D beneficiaries still don't choose the cheapest plans that meet their medication needs
Abstract
When the Medicare Part D prescription drug benefit began in 2006, a primary concern for some policy makers was whether seniors would be able to make smart choices from among the dozens of competing plans. Using 2009 Part D data, we found that only 5.2 percent of beneficiaries chose the cheapest plan. Nationwide, beneficiaries on average spent $368 more annually than they would have spent had they purchased the cheapest plan available in their region, given their medication needs. More than a fifth of beneficiaries spent at least $500 a year more than they needed to. Beneficiaries often overprotected themselves by paying higher premiums for plan features that they did not need, such as generic drug coverage in the coverage gap. Our findings suggest that beneficiaries need more targeted assistance from the government to help them choose plans, such as customized communications about the most cost-effective plans that would cover their medication needs.
Figures
Similar articles
-
Impact of cost sharing on prescription drugs used by Medicare beneficiaries.Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7. Res Social Adm Pharm. 2010. PMID: 20511109
-
Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan.J Health Care Finance. 2011 Winter;38(2):38-53. J Health Care Finance. 2011. PMID: 22372031
-
Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes.Health Serv Res. 2010 Apr;45(2):355-75. doi: 10.1111/j.1475-6773.2009.01071.x. Epub 2009 Dec 30. Health Serv Res. 2010. PMID: 20050931 Free PMC article.
-
Medicare part D: selected issues for plan sponsors, pharmacists, and beneficiaries in 2008.J Manag Care Pharm. 2008 Jan-Feb;14(1):50-60. doi: 10.18553/jmcp.2008.14.1.50. J Manag Care Pharm. 2008. PMID: 18240882 Free PMC article. Review.
-
The private health insurance choices of medicare beneficiaries: how much does price matter?Med Care Res Rev. 2014 Dec;71(6):661-89. doi: 10.1177/1077558714556896. Epub 2014 Nov 4. Med Care Res Rev. 2014. PMID: 25371217 Review.
Cited by
-
Out-of-Pocket Costs for Prostate Cancer Medications Substantially Vary by Medicare Part D Plan: An Online Tool Presents an Opportunity to Mitigate Financial Toxicity.Urol Pract. 2023 Sep;10(5):467-475. doi: 10.1097/UPJ.0000000000000421. Epub 2023 Jun 22. Urol Pract. 2023. PMID: 37347766 Free PMC article.
-
Improving Older Adults' Health by Reducing Administrative Burden.Milbank Q. 2023 Apr;101(S1):507-531. doi: 10.1111/1468-0009.12629. Milbank Q. 2023. PMID: 37096624 Free PMC article.
-
Medicare Part D plan-selection experience: qualitative findings from a national cross-sectional survey.Explor Res Clin Soc Pharm. 2023 Jan 3;9:100219. doi: 10.1016/j.rcsop.2022.100219. eCollection 2023 Mar. Explor Res Clin Soc Pharm. 2023. PMID: 36691455 Free PMC article.
-
Medicare Advantage coverage restrictions for the costliest physician-administered drugs.Am J Manag Care. 2022 Jul 1;28(7):e255-e262. doi: 10.37765/ajmc.2022.89184. Am J Manag Care. 2022. PMID: 35852888 Free PMC article.
-
Coverage of New Drugs in Medicare Part D.Milbank Q. 2022 Jun;100(2):562-588. doi: 10.1111/1468-0009.12565. Epub 2022 May 3. Milbank Q. 2022. PMID: 35502786 Free PMC article.
References
-
- Congressional Budget Office. Spending patterns for prescription drugs under Medicare Part D. [cited 2012 Jan 23];2011 Available from: http://www.cbo.gov/ftpdocs/125xx/doc12548/12-01-MedicarePartD.pdf.
-
- Kaiser Family Foundation. The Medicare prescription drug benefit. [cited 2012 Jan 23];2009 Available from: http://www.kff.org/medicare/upload/7044-09.pdf.
-
- Rice T, Cummings J. Reducing the number of drug plans for seniors: A proposal and analysis of three case studies. J Health Polit Policy Law. 2010;35(6):961–997. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
